These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1971217)

  • 1. Pharmacokinetics and pharmacodynamics of conventional and controlled-release formulations of metipranolol in man.
    Lapka R; Sechser T; Rejholec V; Peterková M; Votavová M
    Eur J Clin Pharmacol; 1990; 38(3):243-7. PubMed ID: 1971217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular responses to metipranolol and timolol eyedrops in healthy volunteers.
    Bacon PJ; Brazier DJ; Smith R; Smith SE
    Br J Clin Pharmacol; 1989 Jan; 27(1):1-5. PubMed ID: 2565117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition kinetics and concentration-effect relationship of metipranolol in patients with cirrhosis and healthy subjects.
    Janků I; Perlík F; Tkaczyková M; Brodanová M
    Eur J Clin Pharmacol; 1992; 42(3):337-40. PubMed ID: 1349528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding.
    Brockmeier D; Hajdù P; Henke W; Mutschler E; Palm D; Rupp W; Spahn H; Verho MT; Wellstein A
    Eur J Clin Pharmacol; 1988; 35(6):613-23. PubMed ID: 2906875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatography of deacetylmetipranolol in plasma.
    Tkaczyková M; Safarík L
    J Pharm Biomed Anal; 1989; 7(12):1805-10. PubMed ID: 2577449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
    Mayer O; Cepelák V; Vitous J; Potmĕsil J
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.
    Battershill PE; Sorkin EM
    Drugs; 1988 Nov; 36(5):601-15. PubMed ID: 2905641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of metipranolol and other blockaders of beta-receptors in experimental animals and man].
    Mayer O; Trcka V
    Cas Lek Cesk; 1982 Sep; 121(34-35):1083-6. PubMed ID: 6127161
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of the concentration of metipranolol eye drops on the drug concentration in human aqueous humour.
    Kessler C; Bleckmann H; Kleintges G
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):487-91. PubMed ID: 1682222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
    Ceremuzynski L; Zaleska T; Nauman J; Nauman A; Zalewski A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):244-9. PubMed ID: 38215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metipranolol and propranolol: no CNS effects of a single oral dose.
    Levander S; Gillner A
    Psychopharmacology (Berl); 1982; 76(4):359-66. PubMed ID: 6126894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of metipranolol in normal man.
    Abshagen U; Betzien G; Kaufmann B; Endele G
    Eur J Clin Pharmacol; 1982; 21(4):293-301. PubMed ID: 6120080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on the ocular and extraocular pharmacology of metipranolol.
    Sugrue MF; Armstrong JM; Gautheron P; Mallorga P; Viader MP
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(3):123-7. PubMed ID: 2858433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacology of Metipranolol (trimepranol injection VUFB, Spofa tablets). The importance of clinical dosages].
    Mayer O; Cepelák V; Vitous J
    Vnitr Lek; 1981 Feb; 27(2):160-71. PubMed ID: 6110280
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
    Vanĕcek M; Trcka V; Helfert I
    Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in cardiac output, induced by metipranolol and other beta-blockers, in dogs.
    Helfert I; Vanĕcek M; Trcka V
    Acta Univ Carol Med (Praha); 1980; 26(7-8):345-9. PubMed ID: 6126107
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol.
    Planz G; Haass H; Lamberts B
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):469-73. PubMed ID: 6128312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular beta-adrenergic blocking effects of bornaprolol in humans: relation to dose and plasma concentration.
    Cheymol G; Jaillon P; Lecoq B; Lecoq V; Cheymol A; Krumenacker M
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):694-8. PubMed ID: 2442536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta adrenergic blocking agents on erythropoiesis in rats.
    Zivný J; Ostádal B; Neuwirt J; Procházka J; Pelouch V
    J Pharmacol Exp Ther; 1983 Jul; 226(1):222-5. PubMed ID: 6134822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.